- Home
- FTHY vs TERN Comparison
FTHY vs TERN Comparison
Compare FTHY & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHY
- TERN
- Stock Information
- Founded
- FTHY 2020
- TERN 2017
- Country
- FTHY United States
- TERN United States
- Employees
- FTHY N/A
- TERN N/A
- Industry
- FTHY Investment Managers
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- FTHY Finance
- TERN Health Care
- Exchange
- FTHY Nasdaq
- TERN Nasdaq
- Market Cap
- FTHY 540.9M
- TERN 634.5M
- IPO Year
- FTHY N/A
- TERN 2021
- Fundamental
- Price
- FTHY $14.65
- TERN $8.18
- Analyst Decision
- FTHY
- TERN Buy
- Analyst Count
- FTHY 0
- TERN 6
- Target Price
- FTHY N/A
- TERN $13.99
- AVG Volume (30 Days)
- FTHY 176.7K
- TERN 1.1M
- Earning Date
- FTHY 01-01-0001
- TERN 11-11-2025
- Dividend Yield
- FTHY 10.93%
- TERN N/A
- EPS Growth
- FTHY N/A
- TERN N/A
- EPS
- FTHY N/A
- TERN N/A
- Revenue
- FTHY N/A
- TERN N/A
- Revenue This Year
- FTHY N/A
- TERN N/A
- Revenue Next Year
- FTHY N/A
- TERN N/A
- P/E Ratio
- FTHY N/A
- TERN N/A
- Revenue Growth
- FTHY N/A
- TERN N/A
- 52 Week Low
- FTHY $12.66
- TERN $1.87
- 52 Week High
- FTHY $14.74
- TERN $10.70
- Technical
- Relative Strength Index (RSI)
- FTHY 49.61
- TERN 68.53
- Support Level
- FTHY $14.63
- TERN $7.01
- Resistance Level
- FTHY $14.84
- TERN $7.67
- Average True Range (ATR)
- FTHY 0.15
- TERN 0.46
- MACD
- FTHY 0.00
- TERN -0.00
- Stochastic Oscillator
- FTHY 56.86
- TERN 97.22
About FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.